| Literature DB >> 20145715 |
Cristi L Galindo1, Scott T Moen, Elena V Kozlova, Jian Sha, Harold R Garner, Stacy L Agar, Ashok K Chopra.
Abstract
We employed Murine GeneChips to delineate the global transcriptional profiles of the livers, lungs, and spleens in a mouse pneumonic plague infection model with wild-type (WT) Y. pestis CO92 and its Braun lipoprotein (Deltalpp) mutant with reduced virulence. These organs showed differential transcriptional responses to infection with WT Y. pestis, but the overall host functional processes affected were similar across all three tissues. Gene expression alterations were found in inflammation, cytokine signaling, and apoptotic cell death-associated genes. Comparison of WT and Deltalpp mutant-infected mice indicated significant overlap in lipopolysaccharide- (LPS-) associated gene expression, but the absence of Lpp perturbed host cell signaling at critical regulatory junctions resulting in altered immune response and possibly host cell apoptosis. We generated a putative signaling pathway including major inflammatory components that could account for the synergistic action of LPS and Lpp and provided the mechanistic basis of attenuation caused by deletion of the lpp gene from Y. pestis in a mouse model of pneumonic plague.Entities:
Year: 2010 PMID: 20145715 PMCID: PMC2817383 DOI: 10.1155/2009/914762
Source DB: PubMed Journal: Comp Funct Genomics ISSN: 1531-6912
Summary of altered gene expression in mice infected with WT Y. pestis CO92, or its Δlpp mutant, compared to uninfected control animals.
| Tissue | Control versus WT | WT versus Mutant | ||||||
|---|---|---|---|---|---|---|---|---|
| 12 hours | 48 hours | 12 hours | 48 hours | |||||
| Up | Down | Up | Down | Up | Down | Up | Down | |
| Number of Genes | ||||||||
|
| ||||||||
| Liver | 33 | 39 | 966 | 441 | 5 | 6 | 120 | 136 |
| Lung | 37 | 10 | 162 | 30 | — | — | 109 | — |
| Spleen | 44 | 4 | 77 | 1 | 9 | 16 | — | — |
A dash (“—") indicates that no gene expression differences were deemed as statistically significant (fold-change ≥1.5, P value ≤.05). Note that ∼57% (109 out of 192) of WT Y. pestis-induced host transcriptional responses in the lungs of mice infected for 48 hours were perturbed in the absence of lpp.
Figure 2Hierarchical clustering of genes determined to be significantly altered in mice at 12 hours and 48 hours in response to WT Y. pestis CO92 infection (a) and in the livers (b), lungs (c), and spleens (d) of mice infected for 48 hours with a Δlpp mutant of Y. pestis CO92, compared to WT Y. pestis. Clustering was performed using Genespring GX 10.0 on normalized and log transformed signal ratios. The three replicate samples representing the three experimental conditions (uninfected animals and mice infected with WT Y. pestis CO92 or its Δlpp mutant) are labeled as control, WT, and mutant, respectively. Note that mice infected for 48 hours with WT Y. pestis CO92 exhibited a collection of altered gene expressions that were common to all three tissues examined (panel a). Most notably, the three replicates representing tissue (liver, lung, or spleen) infected with the mutant clustered together, and mutant-infected samples clustered apart from uninfected controls and mice infected with WT Y. pestis for each tissue examined (panels b–d). The vertical dendrograms indicate relative similarity between samples (columns), while the horizontal dendrograms indicate clusters for genes (rows). Bright red indicates the highest normalized intensity value, bright blue the lowest, and yellow represents median values.
Genes that were commonly altered in the liver, lung, and spleen of mice infected with WT. Y. pestis CO92 for 48 hours.
| GenBank ID | Gene Name | Function | Control versus WT | ||
|---|---|---|---|---|---|
| Liver | Lung | Spleen | |||
| FC | |||||
| AV309418 | N-myc downstream regulated 1 (Ndrg) | Regulation of progression through cell cycle; inflammatory response; immune response | 23.1 | 17.5 | 14.6 |
| BM234360 | Fibronectin 1 (Fn1) | Acute-phase response | 53 | 29.4 | 6.7 |
| BC010337 | Keratin 7 (Krt7) | Cytokine and chemokine mediated signaling pathway | 2 | 7.3 | 6.5 |
| AY061760 | Nuclear factor, interleukin 3, regulated (Nfil3) | Electron transport; fat cell differentiation | 7.5 | 3.7 | 6.1 |
| AK013239 | Inhibitor of DNA binding 2 (Id2) | Electron transport; cell motility; chemotaxis; inflammatory response; immune response; cell surface receptor linked signal transduction; cell-cell signaling; muscle development; circulation; positive regulation of cell proliferation | 30.5 | 20 | 6 |
| AK013765 | Endothelial cell growth factor 1 (platelet-derived) (Ecgf1) | Immune response | 22.4 | 4.6 | 5.5 |
| BG064671 | A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 4 (ADAMTS4) | Regulation of cell growth; neutrophil apoptosis; inflammatory cell apoptosis; cell motility; immune response; response to virus; antigen processing and presentation; neutrophil chemotaxis; unfolded protein response; negative regulation of myelination; defense response to bacterium; positive regulation of chemokine biosynthesis | 4.2 | 4.3 | 5.4 |
| AK004893 | Inter alpha-trypsin inhibitor, heavy chain 4 (Itih4) | Chemotaxis; inflammatory response; immune response; signal transduction | 8.8 | 9.3 | 5.3 |
| NM_031192 | Renin 1 structural (Ren1) | Regulation of cell growth; regulation of protein amino acid phosphorylation; antiapoptosis; JAK-STAT cascade; negative regulation of insulin receptor signaling pathway | 15 | 4 | 5.3 |
| NM_008326 | Immunity-related GTPase family, M (Irgm) | Immune response | 6.1 | 7.9 | 5.1 |
| AW546137 | Bone morphogenic protein receptor, type II (serine/threonine kinase) (Bmpr2) | Response to stress; stress-activated protein kinase signaling pathway | 2.8 | 2.2 | 5.6 |
| AV328143 | ADP-ribosylation factor-like 4A (Arl4a) | Unknown | 23.7 | 10.4 | 4.3 |
| NM_011722 | Dynactin 6 (Dctn6) | Immune response; cell surface receptor linked signal transduction | 3.7 | 5.2 | 4.2 |
| BB667823 | Ring finger protein 125 (Rnf125) | Immune response; response to virus | 11.1 | 7.2 | 4.1 |
| BB561053 | Zinc finger, MYND domain containing 11 (Zmynd11) | Acute-phase response | 3.6 | 11.9 | 4 |
| AF004023 | Cd200 antigen (Cd200) | Chemotaxis; inflammatory response; immune response; signal transduction | 2.7 | 3.3 | 3.8 |
| BC025819 | Cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44) | Immune response; cell adhesion; antimicrobial humoral response | 2.5 | 2.3 | 3.8 |
| AK006551 | Coenzyme Q10 homolog B (Coq10b) | Apoptosis; immune response | 20.9 | 11.6 | 3.7 |
| NM_011016 | Orosomucoid 2 (Orm2) | Immune response | 7.4 | 2.9 | 3.5 |
| AF022957 | Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A (Anp32a) | Somitogenesis; response to biotic stimulus; anterior/posterior pattern formation | 3.3 | 2 | 3.1 |
| NM_023462 | Retinol binding protein 7, cellular (Rbp7) | Immune response | 4 | 4.3 | 3 |
| BB223018 | Schlafen 1 (Slfn1) | Electron transport; lactation; regulation of epithelial cell differentiation | 3.5 | 3.5 | 2.8 |
| BG076338 | F-box protein 21 (Fbxo21) | Immune response | 11.1 | 4.2 | 2.7 |
| NM_008458 | Serine (or cysteine) peptidase inhibitor, clade A, member 3C (Serpina3c) | Regulation of progression through cell cycle; fever; apoptosis; inflammatory response; immune response; cell proliferation; regulation of cell proliferation; antimicrobial humoral response; neutrophil chemotaxis; positive regulation of chemokine biosynthesis; positive regulation of IL-6 biosynthesis; leukocyte migration | 7.2 | 7.1 | 2.5 |
| AF047725 | Cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38) | Unknown | 2.5 | 2.6 | 2.5 |
| BC018333 | Aldo-keto reductase family 1, member D1 (Akr1d1) | NAD biosynthesis; pyridine nucleotide biosynthesis | 4.1 | 2.4 | 2.5 |
| BC021340 | Poly (ADP-ribose) polymerase family, member 14 (Parp14) | Immune response | 4 | 7.8 | 2.4 |
| BB326709 | Doublecortin and CaM kinase-like 3 (Dcamkl3) | Protein folding | 2.4 | 8.1 | 2.4 |
| AF030178 | Phosphatidylinositol glycan anchor biosynthesis, class Q (Pigq) | Cytokine and chemokine mediated signaling pathway | 3.8 | 5.4 | 2.3 |
| NM_008262 | One cut domain, family member 1 (Onecut1) | Phagocytosis; apoptosis; inflammatory response; immune response; cell surface receptor linked signal transduction | 30.9 | 4.3 | 2.3 |
Fold changes (FCs) shown were statistically significant (i.e., Benjamini and Hochberg corrected P value <.05 and absolute consistency across all replicate experiments). A negative sign before values indicates downregulation.
Figure 3A graphical representation of the changes observed in transcriptional profiles of WT Y. pestis CO92-infected mouse spleens at 48 hours post infection. Genes or gene products are represented as nodes and the biological relationship is represented as a line. All lines are supported by at least one reference from literature, textbook, or from canonical information stored in the Ingenuity Pathways Knowledge Base. The red color indicates transcriptional upregulation, based on microarray results. Those signaling molecules which were not colored (e.g., NF-κB complex) were not transcriptionally altered; however, microarray data suggested they were activated non-transcriptionally.
Comparison of transcriptional alterations in mice infected with WT Y. pestis CO92 (this study) and a strain that is avirulent in humans (Y. pestis strain 201, previous study reported by Liu et al. [21]).
| This study | Liu et al. | ||||
|---|---|---|---|---|---|
| Gene | FC | Tissue | Gene | FC | Tissue |
| CD34 | 3.7 | Liver | CD34 | 2.2 | Liver |
| Ifitm1 | 3.3 | All | Ifitm3 | 2.7 | Liver |
| Ifitm6 | 4.4 | Lung | |||
| Tgfbr2 | 2.3 | Liver | Tgfb3 | 2.5 | Liver |
| −3 | Lung | ||||
| Tnfsf10 | 2.3 | Liver | Tnfrsf1a | 2.3 | Liver |
| Tnfrsf13b | 2.3 | Lung | |||
| Ccl20 | 2.4 | Lung | Ccl20 | 7.5 | Lung |
| Cd14 | 12.5 | All | Cd14 | 14.1 | Lung & Liver |
| Csf3 | 6.6 | All | Csf3 | 5 | Lung |
| Cxcl2 | 39.8 | Lung & Liver | Cxcl2 | 14.2 | Lung & Liver |
| Cxcl5/6 | 9.5 | All | Cxcl5/6 | 2.6 | Lung |
| IL-1b | 5.6 | All | IL-1b | 4.8 | Lung |
| IL2rg | 2.9 | Liver | IL2rb | 2.5 | Lung |
| Tnfaip8 | 2 | Liver | Tnfaip8 | 2.3 | Lung |
| Cd9 | 2.8 | Liver | Cd9 | 2.4 | Liver |
| −2.6 | Lung | ||||
| Icam2 | 2.8 | Liver | Icam2 | 1.9 | Liver |
| −3.1 | Lung | ||||
| IFN- | 4.6 | All | IFN- | −2.2 | Lung |
| Igfbp1 | 3.7 | Liver | Igfbp1 | 3.2 | Liver |
| Igfbp4 | 2.1 | ||||
| Lbp | 4.2 | Liver | Lbp | 4.2 | Liver |
| Ndrg | −2 | Liver | Ndrg1 | Up | ? |
| Gadd45g | 8.3 | Liver | Gadd45g | Up | ? |
| MT1 | 5.1 | Lung & Liver | MT1 | Up | Lung & Liver |
| MT2 | 9.2 | Lung & Liver | MT2 | Up | Lung & Liver |
For this study, fold changes (FCs) shown are averages across affected tissues. Only alterations that were determined to be statistically significant (i.e., Benjamini and Hochberg corrected P value <.05 and absolute consistency across all replicate experiments) are included. A negative sign before values indicates downregulation.
Figure 1Venn diagram showing the overlap of major functions of genes identified as significantly altered in the liver, spleen, and lung of mice infected with WT Y. pestis CO92. Functions were obtained using Ingenuity software, with genes identified at 12 hours or 48 hours in each tissue type analyzed separately. Fisher's Exact Test was used as the scoring method for determining significance of overrepresented molecular functions and pathways.
Selected gene expression alterations in the liver, lung, and spleen of mice infected with a Δlpp mutant of Y. pestis CO92, compared to WT Y. pestis.
| GenBank ID | Gene Name | WT versus Mut | C versus WT | C versus Mut |
|---|---|---|---|---|
| FC | ||||
| Liver 12 hours | ||||
|
| ||||
| K01391 | B.subtilis tryptophan (trp) operon, complete cds. | 25.9 | — | 25.9 |
| BB449248 | Apoptosis inhibitor 5 (Api5) | 3.0 | — | 2.8 |
| L38424 | Bacillus subtilis dihydropicolinate reductase (jojE) | −167.8 | — | −226.1 |
|
| ||||
| GenBank ID | Gene Name | WT versus Mut | C versus WT | C versus Mut |
|
| ||||
| Spleen 12 hours | ||||
|
| ||||
| BB167641 | Cyclin D3 (Ccnd3) | −4.2 | 3.8 | — |
| BC027056 | Microtubule-associated protein, RP/EB family, member 2 (Mapre2) | −2.6 | 2.0 | — |
| BB636266 | Nemo like kinase (Nlk) | −2.3 | 2.1 | — |
| NM_013743 | Pyruvate dehydrogenase kinase, isoenzyme 4 (Pdk4) | −2.7 | 3.1 | — |
| AF402617 | BCL2-antagonist/killer 1 (Bak1) | 3.1 | −2.2 | — |
| NM_009743 | Bcl2-like 1 (Bcl2l1) | 2.4 | −2.3 | — |
| NM_010438 | Hexokinase 1 (Hk1) | 4.8 | −4.8 | — |
| AY058908 | Anti-human CD37 antibody WR17 kappa light chain variable region | 4.0 | −2.4 | 1.6 |
| L41881 | Immunoglobulin kappa chain variable 28 (V28) (Igk-V28) | 3.8 | −1.8 | 2.1 |
| BG141874 | Transthyretin (Ttr) | 3.1 | 3.2 | |
|
| ||||
| Liver 48 hours | ||||
|
| ||||
| AK014526 | Lipin 1 (Lpin1) | −1.8 | 2.3 | |
| BE685667 | Cyclin D3 (Ccnd3) | 2 | 2.1 | |
| AF169388 | Procollagen, type IV, alpha 4 (Col4a4) | 2 | 3.0 | |
| BB305930 | Protocadherin 17 (Pcdh17) | 2.2 | 3.0 | |
| BM122301 | Transforming growth factor, beta receptor III (Tgfbr3) | 1.8 | 2.6 | |
| BC025105 | V-set and immunoglobulin domain containing 4 (Vsig4) | −2.3 | — | −2.8 |
| NM_015780 | Complement factor H-related 1 (Cfhr1) | −2.9 | −3.4 | |
|
| ||||
| Lung 48 hours | ||||
|
| ||||
| BC011338 | Baculoviral IAP repeat-containing 3 (Birc3) | 1.83 | — | 2.2 |
| L16462 | B-cell leukemia/lymphoma 2 related protein A1a (Bcl2a1a) | 2.34 | — | 3.5 |
| NM_007651 | CD53 antigen (Cd53) | 1.99 | — | 2.1 |
| AF252873 | Chemokine (C-X-C motif) ligand 14 (Cxcl14) | 2.71 | — | 2.7 |
| BC024886 | Coagulation factor III (F3) | 2.18 | — | 2.4 |
| NM_007972 | Coagulation factor X (F10) | 2.41 | — | 3 |
| BM238701 | Dual specificity phosphatase 16 (Dusp16) | 2.63 | — | 2.7 |
| NM_007913 | Early growth response 1 (Egr1) | 3.03 | — | 3 |
| AF065917 | Leukemia inhibitory factor (Lif) | 3.36 | — | 4.7 |
| BB491008 | MARCKS-like 1 | 2.96 | — | 3.6 |
| BB730139 | Prostaglandin E synthase (Ptges) | 2.55 | — | 3 |
Fold changes (FCs) shown were statistically significant (i.e., Benjamini and Hochberg corrected P value <.05 and absolute consistency across all replicate experiments). A negative sign before values indicates downregulation. A dash “—" indicates that no statistical difference was observed. WT and mutant (Mut) refer to wild-type Y. pestis CO92 and its Δlpp mutant, respectively. C: control (uninfected) mice.
Figure 4Putative host signaling pathway induced by Y. pestis bacterial effectors, LPS and Lpp. TLR-2, TLR-4, CD14, and INF-γ were transcriptionally upregulated in host tissues in response to WT Y. pestis infection. Binding of TLR-4 by LPS and TLR-2 by Lpp is inferred from literature and canonical pathway databases (e.g., Biocarta). Myd88 and IRAK, which are TLR adaptor molecules, were upregulated by WT. Y. pestis, resulting in the activation of mitogen-activated protein kinases (MAPKs), three of which (Map3k6, Map3k8, and Map4k5) were transcriptionally upregulated in WT Y. pestis-infected mice based on microarray analysis results. MAPKs are known to phsophorylate and activate nemo-like kinase (Nik), which was upregulated in WT bacteria-infected mice but not in animals infected with the Δlpp mutant. Phosphorylation of Nik is known to cause activation of NF-κB, which was also transcriptionally upregulated in WT Y. pestis-infected mice. Engagement of IFN-γ to its receptor also leads to NF-κB activation via STAT 2 and 3, which were upregulated in WT Y. pestis-infected animals. NF-κB activation results in transcription of proinflammatory cytokines, which were indeed upregulated based on microarray analysis (examples are listed in the diagram). The three MAPKs that were transcriptionally upregulated based on microarray analysis are known activators of c-jun N-terminal kinases (JNK) which leads to activation of Elk-1 and AP-1 transcription factors. AP-1 is composed of c-Jun and Fos subunits, both of which were upregulated in WT infected mice. Leukemia inhibitory factor (Lif) was uniquely upregulated in mice infected with the mutant and thus is likely inhibited in the presence of lpp, as shown. Cyclin D3 (Ccnd3) was uniquely upregulated in the spleen of WT-infected mice and the lung of Δlpp mutant infected mice and leads to increased cell proliferation. Prostaglandin E synthase (Ptges), Bak1, Bcl2l1, and hexokinase 1 (Hk1) are all known to regulate apoptosis. Each of the genes encoding these proteins was differentially expressed in Δlpp mutant-infected animals, compared to those infected with WT Y. pestis. Most likely, Lpp contributes to inhibition of host cell apoptosis and modulates inflammatory responses in coordination with LPS [22].